Amy Conrad

Contacto de Relaciones con Inversores en TYRA BIOSCIENCES, INC. .

Health Technology

Cargos activos de Amy Conrad

Empresas	Cargo	Inicio	Fin
TYRA BIOSCIENCES, INC.	Contacto de Relaciones con Inversores	-	-
TYRA BIOSCIENCES, INC.	Public Communications Contact	-	-
Juniper Point, Inc.	Director Ejecutivo	-	-

Empresas	Cargo	Inicio	Fin
REGULUS THERAPEUTICS INC.	Contacto de Relaciones con Inversores	-	01/01/2016
REGULUS THERAPEUTICS INC.	Public Communications Contact	-	01/01/2016
BIONANO GENOMICS, INC.	Contacto de Relaciones con Inversores	-	-
Anadys Pharmaceuticals, Inc. Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.	Contacto de Relaciones con Inversores	23/08/2011	-
	Public Communications Contact	26/05/2010	-

Internacional

Estados Unidos

Operativa

Investor Relations Contact	4
Public Communications Contact	3
Chief Executive Officer	1

Sectorial

Health Technology

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	2
Anadys Pharmaceuticals, Inc. Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.	Health Technology
Juniper Point, Inc.

Empresas privadas

Health Technology

Juniper Point, Inc.